Xinrui Group

New Ray Medicine International Holding Limited is a prominent pharmaceutical distributor and trading group based in China, primarily operating through its subsidiaries in Zhejiang Province. The company specializes in the distribution and marketing of pharmaceutical products, including antibiotics, cardiovascular drugs, and gastrointestinal medications, sourced from various manufacturers. It maintains a robust distribution network across several provinces in China, providing integrated supply chain services to hospitals and pharmacies. New Ray Medicine is publicly listed on the Hong Kong Stock Exchange and focuses on expanding its product portfolio through strategic partnerships and acquisitions within the Chinese healthcare market.